NuCana plc has a total of 246 patent applications. It increased the IP activity by 91.0%. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are EPIGENETICS PHARMA LLC, SICHUAN WAN AN DENDROBIUM INDUSTRY DEV CO LTD and IDENIX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 29 | |
#2 | United States | 27 | |
#3 | Australia | 24 | |
#4 | Israel | 18 | |
#5 | Canada | 14 | |
#6 | Republic of Korea | 13 | |
#7 | Singapore | 13 | |
#8 | Brazil | 11 | |
#9 | Chile | 11 | |
#10 | Mexico | 11 | |
#11 | United Kingdom | 10 | |
#12 | Philippines | 10 | |
#13 | China | 9 | |
#14 | WIPO (World Intellectual Property Organization) | 8 | |
#15 | EAPO (Eurasian Patent Organization) | 7 | |
#16 | Hungary | 7 | |
#17 | Serbia | 6 | |
#18 | Japan | 5 | |
#19 | Hong Kong | 4 | |
#20 | Montenegro | 4 | |
#21 | Taiwan | 3 | |
#22 | Morocco | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Optics | |
#5 | Micro-structure and nano-technology | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Griffith Hugh | 156 |
#2 | Serpi Michaela | 53 |
#3 | Mcguigan Christopher | 50 |
#4 | Slusarczyk Magdalena | 41 |
#5 | Kennovin Gordon | 32 |
#6 | Kotala Mani Bushan | 25 |
#7 | Hugh Griffith | 24 |
#8 | Dammalapati Venkata Lakshmi Narasimha Rao | 24 |
#9 | Ferrari Valentina | 23 |
#10 | Pepper Chris | 18 |
Publication | Filing date | Title |
---|---|---|
GB202102519D0 | Antiviral therapy | |
GB202008941D0 | Synthesis of diphosphate derivatives | |
GB202004504D0 | Salt | |
GB202004321D0 | Anticancer compounds | |
GB202003212D0 | Antiviral therapy | |
GB201908444D0 | Synthesis of diphosphate derivatives | |
GB201904544D0 | Anticancer compounds | |
GB201904190D0 | Salt | |
GB201902705D0 | Anticancer compounds | |
GB201820685D0 | Synthesis of 8-chloroadenosine derivatives | |
KR20190015355A | Adenosine derivatives used in cancer treatment | |
CA3025442A1 | Cancer treatments | |
KR20180096698A | Combination therapy | |
AU2015418015A1 | Combination therapy | |
AU2015411525A1 | Combination therapy | |
CA2985540A1 | Use of nuc-1031 in the treatment of cancer |